We bring together best-in-class technologies, advanced science capabilities, and outstanding standards of operational excellence. Our highly integrated portfolio of nutritional, natural, and renewable ingredients targets above-average, innovation-led growth in each of the markets we serve.
ESRS SBM-1
Our Business Units
Our activities are organized into four distinct Business Units:
- Perfumery & Beauty (P&B) is a leading creation and innovation partner for the most iconic global and local brands in consumer goods, lifestyle, and luxury beauty. P&B is home to some of the best talents in the industry, boasts an unmatched palette of ingredients including captives, and is supported by a vertically integrated supply chain. Powered by our science-based innovations in our Perfumery, Ingredients, and Beauty & Care segments, we make our customers’ products more essential, desirable, and sustainable, thereby driving consumer preferences.
- Taste, Texture & Health (TTH) tackles some of society’s greatest and most pressing challenges. We provide nutritious, healthy, and sustainable food and beverage solutions that support the acceleration of the diet transformation with appealing taste and texture and help nourish the rapidly growing global population while contributing to the reduction of food loss and waste. TTH consists of Taste, which includes flavors, natural extracts, and sugar reduction solutions; and Ingredients Solutions, which includes everything from food enzymes to hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins.
- Health, Nutrition & Care (HNC) contributes to the health of the world’s growing population by delivering a wide range of innovative nutrition and care solutions. These support well-being and proactive health at every stage of life and for every lifestyle. HNC serves the early life nutrition, dietary supplements, pharmaceutical, medical nutrition, and biomedical materials markets, as well as the nutrition improvement sector. HNC provides a suite of customized solutions (premix, market-ready solutions, and personalized nutrition) as well as a range of expert services in regulatory affairs and nutrition.
- Animal Nutrition & Health (ANH) helps deliver healthy animal proteins efficiently and sustainably, while harnessing the power of data to make animal farming practices more sustainable, productive, and transparent. With a portfolio of vitamins, performance solutions, and data-driven precision services, ANH serves the entire animal production value chain, helping to shape the future of animal farming. Our solutions enable the production of high-quality animal protein while also reducing emissions and the world’s reliance on natural resources.
Science & Research
Each Business Unit partners closely with its customers to push the boundaries of the possible. They do this by drawing on the expert capabilities of our eight research platforms:
- Biotechnology
- Microbiome research
- Receptor biology and sensory sciences
- AI and data science
- Chemical and process sciences
- Formulation and material sciences
- Analytical sciences
- Nutritional and food sciences
These platforms fuel our innovation pipeline across nutrition, health, and beauty, and build upon our record of innovation-driven growth.
Our journey to creating a Category of One
In 2023, amid challenging macroeconomic conditions and low vitamin prices, we took decisive actions to accelerate our integration, transform our vitamins business and review our portfolio.
We launched a €200 million vitamin transformation program and accelerated the delivery of our synergies, which are expected to contribute approximately €350 million to Adjusted EBITDA.
We completed a strategic business and portfolio review, making a thorough assessment of market attractiveness, right to win, and capital efficiency across all our activities.
We have recognized that the ANH business would thrive better under different ownership, leading to our announcement in February 2024 to separate this Business Unit from the Group.
Our strategic review also led us to de-prioritize certain segments, including non-differentiated vitamins, aroma ingredients, agro ingredients, yeast extracts, and marine lipids. This allowed us to better focus on high-growth, high-margin areas in nutrition, health, and beauty.
In the course of 2024, we sold our marine lipids, yeast extracts, and our minority stake in Robertet. On February 11, 2025, we announced the sale of our stake in the Feed Enzymes Alliance for €1.5 billion to our equal partner Novonesis.
Continuing our journey as a Category of One
After the divestment of our ANH Business Unit planned for 2025 and the finalization of the portfolio tuning, dsm-firmenich will fully focus on strengthening its position in nutrition, health, and beauty.
We will prioritize opportunities for above-average organic growth, focusing on high-growth, high-margin segments and carefully calibrating our business steering to deliver superior performance across all our businesses.
This will create the conditions to accelerate our growth and intensify our performance as a Category of One.
We will achieve this by concentrating on three macro-trends that indicate a growing demand for a holistic approach to well-being:
- An increasing focus on lifespan vitality
- A growing awareness of the potential of preventative healthcare
- Rising expectations concerning well-being
Each segment has a clear mandate for value creation, and our investment policy follows these mandates. This approach, aligned with global macro trends, ensures smart, impactful progress toward our mid-term targets. Our unique business model allows us to fully exploit these market opportunities.
